APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 69 filers reported holding APPLIED THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 3.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,182,573 | +94.5% | 474,929 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $607,909 | +4.1% | 474,929 | -34.0% | 0.00% | 0.0% |
| Q1 2023 | $583,942 | +6.7% | 719,938 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $547,153 | -65.8% | 719,938 | -58.1% | 0.00% | -66.7% |
| Q3 2022 | $1,600,000 | -40.5% | 1,719,938 | -39.3% | 0.01% | -45.5% |
| Q2 2022 | $2,688,000 | -50.0% | 2,835,000 | +11.2% | 0.01% | -47.6% |
| Q1 2022 | $5,378,000 | -46.1% | 2,549,000 | +128.8% | 0.02% | -47.5% |
| Q4 2021 | $9,970,000 | -40.8% | 1,114,000 | +9.7% | 0.04% | -45.9% |
| Q3 2021 | $16,853,000 | +64.7% | 1,015,271 | +106.1% | 0.07% | +60.9% |
| Q2 2021 | $10,234,000 | +82.9% | 492,500 | +65.1% | 0.05% | +76.9% |
| Q1 2021 | $5,595,000 | +58.9% | 298,300 | +86.4% | 0.03% | +52.9% |
| Q4 2020 | $3,522,000 | +39.5% | 160,000 | +31.6% | 0.02% | +30.8% |
| Q3 2020 | $2,525,000 | -69.5% | 121,614 | -46.8% | 0.01% | -75.9% |
| Q2 2020 | $8,268,000 | -52.2% | 228,724 | -56.8% | 0.05% | -61.7% |
| Q1 2020 | $17,309,000 | – | 529,474 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,032,123 | $9,238,000 | 5.08% |
| Orbimed Advisors | 2,313,681 | $20,707,000 | 0.27% |
| EMERALD ADVISERS, LLC | 611,525 | $5,473,000 | 0.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 631,922 | $5,656,000 | 0.20% |
| Rock Springs Capital Management LP | 701,680 | $6,280,000 | 0.14% |
| Kore Private Wealth LLC | 125,000 | $1,119,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $179,000 | 0.13% |
| Artal Group S.A. | 400,000 | $3,580,000 | 0.10% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 517,107 | $4,628,000 | 0.05% |
| Point72 Asset Management, L.P. | 1,114,000 | $9,970,000 | 0.04% |